Nestler EJ, Hyman SE, Malenka RC. Molecular neuropharmacology: a foundation for clinical neuroscience. McGraw-Hill Medical 2001.
Johansen K, Johansen K, Brasseur D, MacDonald N, et al. Where are we in our understanding of the association between narcolepsy and one of the 2009 adjuvanted influenza A (H1N1) vaccines? 2016; 44(4): 276-80.
Edwards K, Hanquet G, Black S, et al. Meeting report narcolepsy and pandemic influenza vaccination: What we know and what we need to know before the next pandemic? A report from the 2nd IABS meeting. Biologicals 2019; 60: 1-7.
Granath F, Gedeborg R, Smedje H, Feltelius N, et al. Change in risk for narcolepsy over time and impact of definition of onset date following vaccination with AS03 adjuvanted pandemic A/H1N1 influenza vaccine (P andemrix) during the 2009 H1N1 influenza pandemic. Pharmacoepidemiol Drug Saf 2019; 28(8): 1045-53.
Sanz Fadrique R, Martín Arias L. Molina-Guarneros JA1, Jimeno Bulnes N, García Ortega P. Guillain-Barré syndrome and influenza vaccines: current evidence. Rev Esp Quimioter 2019; 32(4): 288-95.
Sandhu SK, Hua W, MaCurdy TE, et al. Near real-time surveillance for Guillain-Barre syndrome after influenza vaccination among the Medicare population, 2010/11 to 2013/14. Vaccine 2017; 35(22): 2986-92.
Rieckmann A, Hærskjold A, Benn CS, Aaby P, Lange T, Sørup S. Measles, mumps and rubella vs diphtheria-tetanus-acellular-pertussis-inactivated-polio-Haemophilus influenzae type b as the most recent vaccine and risk of early ‘childhood asthma’. Int J Epidemiol 2019. pii: dyz062
Robinson H, Russell M. Csokonay WJCdwrRhdmaC Japanese encephalitis vaccine and adverse effects among travellers. 1991; 17(32): 173.
Mohan Rao CV, Risbud AR, Dandawate CN, et al. Serological response to Japanese encephalitis vaccine in a group of school children in South Arcot district of Tamil Nadu. Indian J Med 1993; 97: 53-9.
Graur D, Li W-H. Fundamentals of molecular evolution. 2nd ed. 2000.